AR010650A1 - COMPUESTO DERIVADO DE CEFEm, COMPOSICION FARMACEUTICA QUE LO CONTIENE Y USO DEL MISMO - Google Patents
COMPUESTO DERIVADO DE CEFEm, COMPOSICION FARMACEUTICA QUE LO CONTIENE Y USO DEL MISMOInfo
- Publication number
- AR010650A1 AR010650A1 ARP970105544A ARP970105544A AR010650A1 AR 010650 A1 AR010650 A1 AR 010650A1 AR P970105544 A ARP970105544 A AR P970105544A AR P970105544 A ARP970105544 A AR P970105544A AR 010650 A1 AR010650 A1 AR 010650A1
- Authority
- AR
- Argentina
- Prior art keywords
- cefem
- pharmaceutical composition
- group
- tetrazole
- halogen
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 150000003536 tetrazoles Chemical class 0.000 abstract 2
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 229960003085 meticillin Drugs 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 abstract 1
- 229920002554 vinyl polymer Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/36—Methylene radicals, substituted by sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3404696P | 1996-11-27 | 1996-11-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR010650A1 true AR010650A1 (es) | 2000-06-28 |
Family
ID=21873971
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970105544A AR010650A1 (es) | 1996-11-27 | 1997-11-26 | COMPUESTO DERIVADO DE CEFEm, COMPOSICION FARMACEUTICA QUE LO CONTIENE Y USO DEL MISMO |
Country Status (17)
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6265394B1 (en) * | 1997-07-31 | 2001-07-24 | Bristol-Myers Squibb Company | Bis quaternary MRSA cephem derivatives |
| KR20020085181A (ko) * | 2001-05-07 | 2002-11-16 | 주식회사 엘지생명과학 | 신규 세팔로스포린계 항생제 및 이의 제조 방법 |
| KR20020085180A (ko) * | 2001-05-07 | 2002-11-16 | 주식회사 엘지생명과학 | 신규 세팔로스포린계 항생제 및 이의 제조 방법 |
| KR20020085178A (ko) * | 2001-05-07 | 2002-11-16 | 주식회사 엘지생명과학 | 신규 세팔로스포린계 항생제 및 이의 제조 방법 |
| KR20020085176A (ko) * | 2001-05-07 | 2002-11-16 | 주식회사 엘지생명과학 | 신규 세팔로스포린계 항생제 및 이의 제조 방법 |
| KR20030071311A (ko) * | 2002-02-28 | 2003-09-03 | 주식회사 엘지생명과학 | 신규 세팔로스포린 화합물 및 그의 제조방법 |
| EP2709983B1 (en) * | 2011-05-18 | 2018-04-18 | Syngenta Participations AG | Insecticidal compounds based on arylthioacetamide derivatives |
| CN105131018B (zh) * | 2015-09-23 | 2017-12-26 | 浙江华方药业股份有限公司 | 一种头孢替唑酸的制备方法 |
| CN114957056A (zh) * | 2021-02-20 | 2022-08-30 | 帕潘纳(北京)科技有限公司 | 制备3-甲基-2-氯-4-甲基磺酰基苯甲酸甲酯及其中间体的方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3345366A (en) * | 1967-02-15 | 1967-10-03 | American Cyanamid Co | Substituted 7-acetylamino cephalosporanic acids |
| US4148997A (en) * | 1977-11-07 | 1979-04-10 | Yeda Research And Development Co., Ltd. | 7-[Sulfomethyl)phenyl]acetamidocephalosporin derivatives |
| US5567698A (en) * | 1995-02-15 | 1996-10-22 | Bristol-Myers Squibb Company | Pyridinium thiomethyl substituted chepholosporin derivatives |
| US5620969A (en) * | 1995-04-25 | 1997-04-15 | Bristol-Myers Squibb Company | Cephalosporin derviatives |
| WO1997022611A1 (en) * | 1995-12-20 | 1997-06-26 | Bristol-Myers Squibb Company | Cephalosporin derivatives |
-
1997
- 1997-11-19 TW TW086117285A patent/TW414796B/zh not_active IP Right Cessation
- 1997-11-21 AU AU53652/98A patent/AU734948B2/en not_active Ceased
- 1997-11-21 CZ CZ991853A patent/CZ185399A3/cs unknown
- 1997-11-21 KR KR1019990704689A patent/KR20000057283A/ko not_active Withdrawn
- 1997-11-21 WO PCT/US1997/021785 patent/WO1998023621A1/en not_active Application Discontinuation
- 1997-11-21 CA CA002272717A patent/CA2272717A1/en not_active Abandoned
- 1997-11-21 CN CN97199930A patent/CN1238775A/zh active Pending
- 1997-11-21 EP EP97950724A patent/EP0966472A1/en not_active Ceased
- 1997-11-21 BR BR9713350-7A patent/BR9713350A/pt unknown
- 1997-11-21 IL IL12943797A patent/IL129437A0/xx unknown
- 1997-11-21 JP JP52485698A patent/JP2001506607A/ja active Pending
- 1997-11-21 HU HU9903621A patent/HUP9903621A3/hu unknown
- 1997-11-21 PL PL97334558A patent/PL334558A1/xx unknown
- 1997-11-21 NZ NZ335892A patent/NZ335892A/en unknown
- 1997-11-26 AR ARP970105544A patent/AR010650A1/es unknown
- 1997-11-26 ZA ZA9710662A patent/ZA9710662B/xx unknown
-
1999
- 1999-05-26 NO NO992526A patent/NO992526L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO992526D0 (no) | 1999-05-26 |
| CN1238775A (zh) | 1999-12-15 |
| IL129437A0 (en) | 2000-02-17 |
| AU5365298A (en) | 1998-06-22 |
| BR9713350A (pt) | 2000-01-25 |
| HUP9903621A3 (en) | 2001-05-28 |
| EP0966472A1 (en) | 1999-12-29 |
| KR20000057283A (ko) | 2000-09-15 |
| HUP9903621A2 (hu) | 2000-04-28 |
| JP2001506607A (ja) | 2001-05-22 |
| ZA9710662B (en) | 1999-05-26 |
| NZ335892A (en) | 2001-07-27 |
| CZ185399A3 (cs) | 1999-08-11 |
| NO992526L (no) | 1999-05-26 |
| WO1998023621A1 (en) | 1998-06-04 |
| EP0966472A4 (enrdf_load_stackoverflow) | 1999-12-29 |
| PL334558A1 (en) | 2000-03-13 |
| CA2272717A1 (en) | 1998-06-04 |
| AU734948B2 (en) | 2001-06-28 |
| TW414796B (en) | 2000-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO954072L (no) | Vannopplöselige camptotecinderivater, fremgangsmåte for deres fremstilling og deres anvendelse som antitumormidler | |
| BRPI0014526B8 (pt) | compostos cíclicos de seis elementos contendo nitrogênio aromático, composição farmacêutica e uso do mesmo | |
| ES2196344T3 (es) | Derivados de sulfonamida y su uso en el tratamiento de trastornos de snc. | |
| MXPA03005583A (es) | Derivados de carbamato de quinuclidina y su uso como antagonistas m3. | |
| CA2036304A1 (en) | Pyrimidinedione derivatives, their production and use | |
| HUP0003921A2 (hu) | VLA-4 által közvetített leukocitaadhéziót gátló szulfonilezett dipeptidszármazékok, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk | |
| ATE129714T1 (de) | Heterocyclische biphosphonsäurederivate. | |
| EP0348523A4 (en) | Thienodiazepine compounds and their medicinal use | |
| DE69720551D1 (de) | Makrozyklische derivate von erythromycin a und b mit 13 ringatomen | |
| HUP0104452A2 (hu) | Triciklusos vegyületeket tartalmazó gyógyászati kompozíció | |
| TR200103395T2 (tr) | 13-metil eritromisin türevleri. | |
| DK0388948T3 (da) | Acryloylsubstituerede pyrrolderivater | |
| EP0339959A3 (en) | Lactam derivatives | |
| NO924929L (no) | Farmasoeytisk aktive benzoquinazolinforbindelser | |
| AR010650A1 (es) | COMPUESTO DERIVADO DE CEFEm, COMPOSICION FARMACEUTICA QUE LO CONTIENE Y USO DEL MISMO | |
| ATE186301T1 (de) | An den positionen 2 und 9 substituierte 4h-pyrido-(1,2-a)pyrimidin-4-one | |
| EP0385722A3 (en) | Tricyclic lactam derivatives and pharmaceutical compositions containing them | |
| DE69920362D1 (de) | Neue Makrolidderivate | |
| DK0406119T3 (da) | Hidtil ukendte peptidderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem | |
| ES2098023T3 (es) | Compuestos de estructura guanidinica y composiciones farmaceuticas que los contienen. | |
| BRPI0508768A (pt) | derivado de benzopirano da fórmula (i) ou (ii), ou sal farmaceuticamente aceitável do mesmo, medicamento e medicamento para o tratamento de arritmia | |
| PE25998A1 (es) | DERIVADOS DE OCTAHIDRO-PIRROLO(1,2-a)-PIRAZINA 2,7-SUSTITUIDOS | |
| ATE174593T1 (de) | Neue bisoxadiazolidinderivate | |
| ATE215555T1 (de) | 17-beta.-allyloxy(thio)alkyl-androstan derivative zur modulation von meiose | |
| MX9806229A (es) | Derivados de benzo(c)quinolicina, su preparacion y uso como inhibidores de la 5alfa-reductasas. |